Ozempic Maker Novo Nordisk to Cut 9,000 Jobs

Start

The Danish drugmaker said it needed to streamline operations and become more agile, as it faces a more competitive and consumer-focused market.

Previous Story

Republicans Race to Advance Stephen Miran, Trump’s Fed Pick, Despite White House Ties

Next Story

Inside Lutnick’s Department of Deal-making